CVS vs ABBV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

CVS

50.0
AI Score
VS
ABBV Wins

ABBV

50.5
AI Score

Investment Advisor Scores

CVS

50score
Recommendation
HOLD

ABBV

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CVS ABBV Winner
Revenue 189.89B 8.24B CVS
Net Income 4.89B 2.75B CVS
Net Margin 2.6% 33.4% ABBV
Operating Income 8.95B 8.82B CVS
ROE 7.8% -94.0% CVS
ROA 2.2% 4.2% ABBV
Total Assets 220.11B 66.16B CVS
Cash 5.19B 8.02B ABBV
Current Ratio 0.92 1.20 ABBV
Free Cash Flow 8.32B 9.52B ABBV

Relative Price Performance (Last 90 Days)

CVS 1M: -0.7% · 3M: -7.6% ABBV 1M: +3.9% · 3M: +18.0%

Current Technical Phase

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $89.79

ABBV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.0% over 20 days), RSI 62

RSI (14): 62.2 · Price: $294.45

Fundamentals Snapshot

Metric CVS ABBV
Market Cap — —
Forward P/E 10.4 18.2
Trailing P/E 10.4 50.7
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.1% 0.7%
Operating Margin 0.0% 0.4%
EPS 8.61 5.82
Dividend Yield 0.03% 0.02%

Frequently Asked Questions

Based on our detailed analysis, ABBV is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.